Humana goes ex-dividend at $.885 per share (a 0.8% annualized dividend yield) on December 28th, 2023. This dividend is included in the potential return-on-investment results detailed below. Also, as preferred, there is no earnings report prior to the options expiration date and analysts' current stock target price is $585.28 per share (+28.3% above today's stock purchase price).
12/20/2023 Sold 1 HUM January 5th, 2024 $445.00 Call option @ $15.42 per share.
12/28/2023 Ex-dividend of $.885 per share.
A possible overall performance result (including commissions) if this position is assigned on its 1/5/2024 option expiration date is as follows:
Covered Calls Net Investment: $44,070.67
= ($456.12 - $15.42) * 100 shares + $.67 commission
Net Profit Components:
(a) Call Option Income: +$1,541.33
= ($15.42 * 100 shares) - $.67 commission
(b) Dividend Income: +$88.50
= $.885 x 100 shares
(c) Capital Appreciation (If Humana stock is above the $445.00 strike price at the January 5th option expiration date): -$1,112.00
= ($445.00 - $456.12) * 100 shares
Potential Total Net Profit (If assigned at expiration): +$517.83
= (+$1,541.33 option income + $88.50 dividend income - $1,112.00 capital appreciation)
Potential Absolute Return-on-Investment: +1.2%
= +$517.83/$44,070.67
Potential Equivalent Annualized-Return-on-Investment: +26.8%
= (+$517.83/$44,070.67) * (365/16 days)